Works Cited

1. Yu A, Chertow G, Luyckx V, Marsden P, Skorecki K, Maarten T (eds). Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2019.

2. Carroll MF, Temte JL. Proteinuria in adults: a diagnostic approach. Am Fam Physician. 2000;62(6):1333-1340.

3. Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003;348:2330-2338.

4. Sokolosky MC. Hematuria. Emerg Med Clin North Am. 2001;19:621-632.

5. Jameson JL, Fauci A, Kasper DL, Hauser S, Longo D, Loscalzo J. Harrison's Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill; 2018.

6. Fiebach NH, Kern DE, Thomas PA, Ziegelstein RC, Barker LR, Zieve PD (eds). Principles of Ambulatory Medicine. 7th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2007.

7. Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE. Clinical testing patterns and cost implications of variation in the evaluation of CKD among U.S. physicians. Am J Kidney Dis. 2009;54(2):227-237.

8. Ahmed Z, Lee J. Asymptomatic urinary abnormalities: hematuria and proteinuria. Med Clin North Am. 1997;81(3):641-652.

9. Thomas B, Lerma EV. Proteinuria. Available at https://emedicine.medscape.com/article/238158-overview. Last accessed May 21, 2021.

10. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Phys. 2005;71(6):1153-1162.

11. Castner D, Douglas C. Now on stage: chronic kidney disease. Nursing. 2005;35(12):58-63.

12. National Kidney Foundation. Kidney Disease: Causes. Available at https://www.kidney.org/atoz/content/kidneydiscauses. Last accessed May 21, 2021.

13. United States Renal Data System. 2019 USRDS Annual Data Report. Volume Two: End-Stage Renal Disease in the United States. Available at https://www.usrds.org/annual-data-report/. Last accessed May 21, 2021.

14. National Institute of Diabetes and Digestive and Kidney Diseases. Albuminuria: Albumin in the Urine. Available at https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/tests-diagnosis/albuminuria-albumin-urine. Last accessed May 21, 2021.

15. Wang TJ, Evans JC, Meigs JB, et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation. 2005;111(11):1370-1376.

16. Dell'Omo G, Penno G, Giorgi D, DiBello V, Mariani M, Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis. 2002;40(1):1-8.

18. Sinnakirouchenan R. Nephrotic Syndrome. Available at https://emedicine.medscape.com/article/244631-overview. Last accessed May 21, 2021.

19. Roozbeh J, Banihashemi MA, Ghezlou M, et al. Captopril and combination therapy of captopril and pentoxifylline in reducing proteinuria in diabetic nephropathy. Ren Fail. 2010;32(2):172-178.

20. Robles NR, Romero B, de Vinuesa EG, et al. Treatment of proteinuria with lercanidipine associated with renin-angiotensin axis-blocking drugs. Ren Fail. 2010;32(2):192-197.

21. Merck Manual. Overview of Nephrotic Syndrome. Available at https://www.merckmanuals.com/professional/genitourinary-disorders/glomerular-disorders/overview-of-nephrotic-syndrome. Last accessed May 21, 2021.

22. National Institute of Diabetes and Digestive and Kidney Diseases. Nephrotic Syndrome in Adults. Available at https://www.niddk.nih.gov/health-information/kidney-disease/nephrotic-syndrome-adults. Last accessed May 21, 2021.

23. Murakami S, Igarashi T, Hara S, Shimazaki J. Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. J Urol. 1990;144(1):99-101.

24. LexiComp Online. Available at https://online.lexi.com/lco/action/login. Last accessed May 21, 2021.

25. Masood S, Jayne D, Karim Y. Beyond immunosuppression: challenges in the clinical management of lupus nephritis. Lupus. 2009;18(2):106-115.

26. Chen Y, Schieppati A, Chen X, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2014;(10):CD004293.

27. Shalhoub PJ, Quek ML. Management of Bladder Cancer in the Elderly: Clinical Decision Making and Guideline Recommendations. Available at https://www.medscape.com/viewarticle/740652. Last accessed May 21, 2021.

28. Mansur A. Minimal-Change Disease Treatment and Management. Available at https://emedicine.medscape.com/article/243348-treatment. Last accessed May 21, 2021.

29. Krane NK. Renal Disease and Pregnancy. Available at https://emedicine.medscape.com/article/246123-overview#aw2aab6b2. Last accessed May 21, 2021.

30. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785-799.

31. Lim KH. Steinberg G. Preeclampsia. Available at https://emedicine.medscape.com/article/1476919-overview. Last accessed May 21, 2021.

32. American Urological Association. Diagnosis, Evaluation and Follow-up of Asymptomatic Microhematuria (AMH) in Adults. Available at https://www.auanet.org/guidelines/archived-documents/asymptomatic-microhematuria-(amh)-guideline. Last accessed May 21, 2021.

33. Pillalamarri N. Shalom D, Sanidad S, Akerman M, Lind L, Winkler H. The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse. Int Urogynecol J. 2015;26(1):85-90.

34. Sharp VJ, Barnes KT, Erickson BA. Assessment of asymptomatic microscopic hematuria in adults. Am Fam Physician. 2013;88(11):747-754.

35. Grossfeld GD. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician. 2001;63(6):1145-1155.

36. Thaller TR, Wang LP. Evaluation of asymptomatic microscopic hematuria in adults. Am Fam Physician. 1999;60(4):1143-1152.

37. Mandal AK, Jennette JC (eds). Diagnosis and Management of Renal Disease and Hypertension. Philadelphia, PA: Lea and Febiger; 1988.

38. National Kidney Foundation. Goodpasture's Syndrome. Available at https://www.kidney.org/atoz/content/goodpasture. Last accessed May 21, 2021.

39. National Kidney Foundation. What is Glomerulonephritis? Available at https://www.kidney.org/atoz/content/glomerul. Last accessed May 21, 2021.

40. Gulati S. Hematuria. Available at https://emedicine.medscape.com/article/981898-overview. Last accessed May 21, 2021.

41. Centers for Disease Control and Prevention. Parasites: Schistosomiasis. Available at https://www.cdc.gov/parasites/schistosomiasis. Last accessed May 21, 2021.

42. Medline Plus. Urinary Casts. Available at https://medlineplus.gov/ency/article/003586.htm. Last accessed May 21, 2021.

43. Friedlander DF, Resnick MJ, You C, Bassett J, Yarlagadda V, Penson DF, et al. Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Am J Med. 2014;127(7):633-640.

44. Ark JT, Alvarez JR, Koyama T, et al. Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race, and risk factors for bladder cancer. J Urol. 2017;198(5):1033-1038.

45. Levine DZ. Caring for the Renal Patient. 3rd ed. London, England: Saunders; 1997.

46. Committee Opinion No. 703 Summary: Asymptomatic Microscopic Hematuria in Women. Obstet Gynecol. 2017;129(6):1153-1154.

47. Mathur M. Urography. Available at https://emedicine.medscape.com/article/1890669-overview. Last accessed May 21, 2021.

48. Expert Panel on Pediatric Imaging: Dillman JR, Rigsby CK, Iyer RS, et al. ACR Appropriateness Criteria hematuria-child.J Am Coll Radiol. 2018;15(5S):S91-S103.

49. Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473-2481.

50. Madeb R, Golijanin D, Knopf J, et al. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria. Urology. 2010;75(1):20-25.

51. Edwards TJ, et al. Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up. BJU Int. 2011;107(2):247-252.

52. Nielsen M, Qaseem A, High Value Care Task Force of the American College of Physicians. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016;164(7):488-497.

53. Medline Plus. Acute Nephritic Syndrome. Available at https://medlineplus.gov/ency/article/000495.htm. Last accessed May 21, 2021.

54. National Institute of Diabetes and Digestive and Kidney Diseases. Lupus and Kidney Disease (Lupus Nephritis). Available athttps://www.niddk.nih.gov/health-information/kidney-disease/lupus-nephritis. Last accessed May 21, 2021.

55. Brent LH, Karhadkar A, Bloom E. Lupus Nephritis. Available at https://emedicine.medscape.com/article/330369-overview. Last accessed May 21, 2021.

56. Houssiau FA, Ginzler EM. Current treatment of lupus nephritis. Lupus. 2008;17(5):426-430.

57. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Am Coll Rheumatol. 2012;64(6):797-808.

58. Khamashta MA. Systemic lupus erythematosus and pregnancy. Best Pract Res Clin Rheumatol. 2006;20(4):685-694.

59. Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin North Am. 2007;33(2):227-235.

60. Witter FR. Management of the high-risk lupus pregnant patient. Rheum Dis Clin North Am. 2007;33(2):253-265.

Evidence-Based Practice Recommendations Citations

1. Nielsen M, Qaseem A, High Value Care Task Force of the American College of Physicians. Hematuria as a marker of occult urinary tract cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2016;164(7):488-497. Available at https://www.acpjournals.org/doi/10.7326/M15-1496. Last accessed June 11, 2021.


Copyright © 2021 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.